For Immediate Release |
4 October 2016 |
ANGLE plc
("ANGLE" or "the Company")
Result of 2016 Annual General Meeting
ANGLE plc (AIM: AGL OTCQX: ANPCY), the specialist medtech company, announces that Resolutions 1 to 8 and Resolution 10 put to its shareholders at today's 2016 Annual General Meeting were duly passed.
Resolution 9 in relation to an approved level for disapplication of statutory pre-emption rights was supported by the majority of Shareholders but did not receive the necessary level of support (75%) to be passed at this time. A reduced level for the disapplication of statutory pre-emption rights has been agreed with institutional shareholders and a further announcement will follow shortly seeking approval of this reduced level.
For further information:
ANGLE plc |
01483 685830 |
Andrew Newland, Chief Executive Ian Griffiths, Finance Director
|
|
Cenkos Securities Stephen Keys (Nominated adviser) Russell Kerr, Oliver Baxendale (Sales)
|
020 7397 8900 |
FTI Consulting Simon Conway, Mo Noonan, Stephanie Cuthbert Kimberly Ha (US) |
020 3727 1000 001 212 850 5612 |